Kolageri S, Hemanth S, Parit M. In-silico ADME prediction and molecular docking study of novel benzimidazole-1,3,4-oxadiazole derivatives as CYP51 inhibitors for antimicrobial activity. J. Appl. Pharm. Res. [Internet]. 2022Sep.30 [cited 2025Jan.21];10(3):28-3. Available from: https://japtronline.com/index.php/joapr/article/view/275